In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Adam Laitman about his unconventional path to becoming a medical director in the pharmaceutical industry. Dr. Laitman shares insights from his career transition from medical school to industry, highlighting the impact of his background in marketing and editorial work. The discussion covers the various career opportunities within medical affairs, the importance of diverse educational backgrounds, and the potential be...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

In this episode of Pharma Sessions, host Jonathan Kaskey discusses career transitions into the pharmaceutical industry, specifically focusing on roles like Medical Science Liaisons (MSLs). The guest, Emet Anceaume is the Director of Field Medical Affairs at Immunovant. Emet is a pharmacist by training. She shares her insights on the importance of transferable skills, the challenges and strategies for breaking into pharma, and the distinction between working for big pharma and small biot...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

In this episode of Pharma Sessions, hosted by Jonathan Kaskey, Vince Turner shares his insights on integrating creativity into operational environments. The discussion covers Vince's career journey from financial services to pharma, and his operational strategies at Kite. Emphasis is placed on the importance of creativity in solving challenges, the value of building strong relationships, and empowering team members. And stay to the end for the buttermilk pancakes recipe (courtesy of Mel...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health. They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks. Introduction and startling data on prescription abuse Welcome and guest introduction Paul Howe's breakfast routine&nb...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional Collaboration In this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of industry experience currently at GSK. They discuss the need for medical affairs to move beyond speaking only to themselves and to engage more openly with other functions within pharmaceutical organizations. Dr. Saeed advocates for a collaborative approach and shares h...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shares his unconventional journey into the medical affairs space, transitioning from political science to consulting, and eventually stepping into various Chief of Staff roles at some of the leading pharmaceutical companies like Shire, Takeda, Abbvie and Ki...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics. They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires. Jen shares her journey from academia to the biopharma industry, driven by her pursuit of a sustainable work-life balance. They delve into practical strategies for integrat...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Future Proofing Medical Affairs: A Conversation with Stephanie Hunter Banks In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evolving healthcare ecosystem. Stephanie shares insights on creating a culture of innovation, leveraging big data and AI, and fostering collaboration within pharma companies. She reflects on her own career journey from pharmacy to leading learning ...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Kaskey's Hierarchy of Needs in Medical Affairs: Steering towards Successful Product Launches This episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position. Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies. The discussion t...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care. They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies. Lars shares his transition from academia to the pharmaceutical industry, the thrill ...

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com